Editorial Board ::: Central Nervous System Agents in Medicinal Chemistry

ISSN: 1875-6166 (Online)
ISSN: 1871-5249 (Print)


Volume 17, 3 Issues, 2017


Download PDF Flyer




Central Nervous System Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Central Nervous System Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Editorial Board

Co-Editors:

G. Aliev (Biography
G. Aliev

Dr. Gjumrakch Aliev, MD, PhD, President “GALLY” International Biomedical Research Institute Inc., San Antonio, Texas, USA. He also hold appointment with the University of Atlanta, as a Professor and as a Leading Scientist , Institute of Physiologically Active Compounds. Russian Academy of Sciences.

He received his MD in 1982, from the Baku Medical University (former USSR) with cum laude. Then he accomplished his PhD in Cardiovascular Diseases from the prestigious Russian Academy of the Medical Sciences, Moscow, Russia in 1988 with cum laude. He authored and coauthored more than 500 publications in the fields of neurodegenerative diseases research (Alzheimer disease), as well as cardio- and cerebrovascular disease, cancer, and electron microscopy.

)

"GALLY" International Biomedical Research Consulting LLC
San Antonio, TX
USA

G.S. Hamilton (Biography
G.S. Hamilton

Dr. Gregory received his bachelor’s and PhD degrees in chemistry from the University of Virginia and worked on the synthesis of complex indole alkaloids. In 1988, he joined Nova Pharmaceuticals Inc. He became the Vice President of Chemistry in 1997.

In 2002, as Vice-President, he joined Artesian Therapeutics in Gaithersburg and designed and patented an IND candidate in a year.

In 2005, he joined MGI PHARMA, as head of the medicinal chemistry. In 2007, he became the Senior Director of Intellectual Property, and in 2008, he worked as senior member of IP group

)

Biopharma Research Leader, Organic and Medical Chemist, Registered US Patent Agent
Catonsville, MD
USA


Associate Editors:

S.O. Bachurin (Biography
S.O. Bachurin

Sergey Bachurin received the Ph.D. degree in 1980. Since 1981 he works in the Institute of Physiologically Active Compounds Russian Academy of Sciences (RAS). Since 2006 he is a Director of the Institute. In 2003 he was elected as a member of RAS. His research activity related to the discovery of novel agents for neurodegenerative diseases treatment. Bachurin was invited scholar in University of California, San Francisco and in Tufts University, Boston. He is Russian national representative in IUPAC and Council member of European Federation of Medicinal Chemistry. He is the author of more than 200 and about 40 patents.

)

Institute of Physiologically Active Compounds Russian Academy of Sciences (IPAC RAS)
Moscow
Russia

D. Zelena (Biography
D. Zelena

Dr. Zelena is a medical doctor (MD) and obtained a doctorate (PhD) in Neuroscience from the Semmelweis University, Budapest, Hungary. She has more than 20 years of experience in the research for new treatment option aimed to treat CNS and neurological disorders. Currently Dr. Zelena is a Senior Scientist of the Hungarian Academy of Sciences, Institute of Experimental Medicine. She is a neuroendocrinologist, and behavioral neuroscientist. Dr. Zelena is also an adjunct faculty member at University of Pécs, Hungary, where she teaches Physiology to medical students. She published more than 95 articles and 14 book chapters.

)

Hungarian Academy of Sciences, Institute of Experimental Medicine
Gvadányi
Hungary

G.L. Mariottini (Biography
G.L. Mariottini

MSc and MD, fellow of the Provincial Medical and Odontological Register (Genova), of the Italian Society of Experimental Biology and of the Solidarity, Projects and Resources for Africa University Board. He worked at the G.Gaslini Pediatric Hospital of Genova carrying out research on neuroblastoma; at present he deals with ecotoxicology, toxicology, and natural extract activity on cultured cells at the University of Genova (Department of Earth, Environment and Life Sciences). He participated in national and international research projects and working groups, is Associate Editor, Editorial Board member and reviewer for international scientific journals, Guest Editor for special issues of journals and books, and author of 152 publications, including 9 teaching books.

)

University of Genova
Genova
Italy

J.L. Neumeyer (Biography
J.L. Neumeyer

Dr. Neumeyer received his BS in Chemistry from Columbia University and PhD in Medicinal Chemistry from the University of Wisconsin, Madison, WI. He joined the faculty of Northeastern University as Professor of Medicinal Chemistry and was appointed Matthews Distinguished Professor. Dr. Neumeyer was a cofounder of Research Biochemicals, Inc. Dr. Neumeyer has had a long career in medicinal chemistry as evidenced in more than 400 scientific publications. He is currently the director of the Medicinal Chemistry Laboratory at McLean Hospital, Harvard Medical School. Dr. Neumeyer was inducted into the American Chemical Society’s Division of Medicinal Chemistry Hall of Fame in 2008.

)

McLean Hospital
Belmont, MA
USA


Regional Editors:

R. Cacabelos (Biography
R. Cacabelos

Dr. Ramón Cacabelos is Professor of Genomic Medicine at Camilo José Cela University, Madrid, and President of the EuroEspes Biomedical Research Center, Corunna, Spain. He received his M.D. from Oviedo University, Ph.D. from Santiago University, and D.M.Sci. (Psychiatry) from Osaka University Medical School, Japan. After a decade at the Department of Psychiatry in Osaka, he returned to Spain and focused his research activity on the genomics and pharmacogenomics of neurodegenerative disorders. He has published over 600 papers and 24 books, and is Editor-in-Chief of the first World Guide for Drug Use and Pharmacogenomics and President of the World Association of Genomic Medicine.

)

Camilo José Cela University
Madrid
Spain

Y.N. Utkin (Biography
Y.N. Utkin

Yuri N. Utkin received his PhD in Bioorganic Chemistry from the Shemyakin Institute of Bioorganic Chemistry of the Academy of Sciences of the USSR. After earning the PhD degree he continued his career at the same Institute (now the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS), receiving a DSc degree in 1996 and being promoted to Professor in 2006. Prof. Utkin is the head of the laboratory of molecular toxinology. He has published more than 150 scientific publications in peer reviewed journals. Professor Utkin is a member of the European Society for Neurochemistry, the International Society on Toxinology, and the American Society for Biochemistry and Molecular Biology.

)

Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry Russian Academy of Sciences (IBCH RAS)
Moscow
Russia

S.H. Fatemi (Biography
S.H. Fatemi

M. Fatemi received his PhD in Electrical Engineering from Purdue University. Currently, he is a Professor of Biomedical Engineering at the Mayo Clinic College of Medicine, and a member of Mayo Clinic Cancer Center, Cancer Imaging Program, and the Center for Translational Science Activities. In addition, he is a faculty member of the Biomedical Informatics and Computational Biology graduate program at the University of Minnesota Rochester. His current research areas include ultrasonic methods for tissue viscoelasticity and nonlinear elasticity estimation for applications in cancer imaging and bladder function evaluation. He is an elected Fellow of IEEE, AIMBE, ASA, and AIUM. He is the recipient of the IEEE-UFFC Distinguished Lecturer award for 2016-2017.

)

University of Minnesota Medical School
Minneapolis
MN
USA

D.Q. Wang (Biography
D.Q. Wang

Prof. D.Q. Wang is Vice-Head at the Department of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University. He obtained his Ph. D from National University of Singapore and he is Postdoctoral Fellow at Stanford University and NHMRC from Australia. He is regular a member of Asia Pacific Society for Neurochemistry, NSFC of China Grant and Committee Member of Chinese Parkinson‘s Disease & Movement Disorders Society, “Frontiers in Cellular Neuroscience”. He was awarded as Young Investigator in 2010 from Ministry of Education. He obtained 26 National Grants and has published 45 SCI papers.

)

Zhujiang Hospital of Southern Medical University
Guangzhou
China

S. Hashioka (Biography
S. Hashioka

Dr. Sadayuki Hashioka is an associate professor of Department of Psychiatry, Shimane University, Izumo, Japan. He received his MD in 1998 from the Faculty of Medicine, University of Miyazaki, Japan. After four years of clinical work as a psychiatrist, he received his PhD in 2006 from the Department of Neuropsychiatry, Kyushu University, Fukuoka, Japan.He subsequently obtained five-year training as a postdoctoral fellow under Drs. Edith and Patrick McGeer at the Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada. Since 2012 he has been at his present post

)

Shimane University
Izumo
Japan


Editorial Board Members:

S.M. Ali (Biography
S.M. Ali

Currently, Dr. Ali is director at ImmunoGen working in the area of immuno-oncology. He has over twenty years of experience in research and development focusing in CNS, inflammation and oncology. His research has delivered several drug candidates for advanced development in CNS and oncology. He has over sixty peer reviewed publications in the journals of international repute, forty patents, review articles and a book chapter covering his research. Dr. Ali obtained his doctorate (Ph. D.) in Chemistry from Aligarh Muslim University in India. He then worked at several research institutions including, Central Drug Research Institute (India), Kyoto University (Japan), University of Paris (France) and University of Kansas (USA). His focus remained on research and advancing drug candidates to treat unmet medical needs.

)

ArQule Inc.
Woburn, MA
USA

F. Corelli (Biography
F. Corelli

F. Corelli was born in Italy. He graduated in Medicinal Chemistry at University of Rome La Sapienza and joined Artico's group. He served as the Chairman of the University of Siena and was appointed in the Scientific Committee of University of Pisa. He was the director of the Workshop in Synthetic Metodologies of the Italian Chemical Society. He is a member of the Steering Committee of the Italian Chemical Society, EABM of Central Nervous System Agents in Medicinal Chemistry and a reviewer for numerous scientific journals. He is the author of 8 patent applications, 198 scientific papers, 8 book chapters , more than 90 oral/poster communications. He has also been editor of a book.

)

Universita' degli Studi de Siena
Siena
Italy

B. Malawska
University Collegium Medicum
Kraków
Poland

C. Ramassamy (Biography
C. Ramassamy

Prof. Charles Ramassamy has successively obtained his DEA (Diploma of Advanced Studies) in Molecular and Cellular Pharmacology at Paris V University, and a PhD in Neuroscience, option neuropharmacology, at the University of Rouen in France. After completing a postdoctoral fellowship at McGill University, at the Douglas Mental Health University Institute Research Center in the laboratory of Dr. Judes Poirier, he became professor of pharmacology at the Université du Québec à Trois-Rivières, then professor at the INRS-Institut Armand-Frappier. He is also an associate professor at Laval University and a regular researcher at the Institute on Nutrition and Functional Foods, Laval University.

)

INRS-Institute Armand-Frappier
Montreal, Quebec
Canada

J. Bandorowicz-Pikula
Nencki Institute of Experimental Biology
Warsaw
Poland

A.G Horti (Biography
A.G Horti

Dr. Horti is an Associate Professor in the Department of Radiology and Radiological Science at Johns Hopkins University, Maryland. He has devoted his career to the development of short-lived radiotracers for PET, in particular radioligands for imaging of cerebral receptors and enzymes in human subjects. His scientific results have been published in various peer-reviewed journals, invited reviews supported by NIH, private foundations and pharmaceutical industry. He also holds appointments on editorial boards for several scientific journals. He is an active member of the Society of Nuclear Medicine and Molecular Imaging and he has organized research sessions and continuing education sessions for a number of SNMMI meetings.

)

Johns Hopkins University
Baltimore, MD
USA

I. Okun
Biology and CTO
San Diego, CA
USA

B.C. Shook
Janssen Pharmaceutical Companies of Johnson & Johnson
Gilbertville, PA
USA

L. Betti (Biography
L. Betti

Dr. Laura Betti, obtained a PhD in Neurobiology and Clinic of Affective Disorders from the University of Pisa, Italy. In the same University she also received her Speciality in Clinical Biochemistry and her Biological Degree. Currently Dr. Betti is Researcher in Biochemistry at the Department of Pharmacy of the University of Pisa. She has over 20 years of the experience in the research of proteins and their role in transduction mechanisms in physiological and pathological conditions. She has published 100 publications in the fields of biochemistry, as well as clinical biochemistry and neurosciences with particular reference to neurotransmitters and receptor systems.

)

University of Pisa
Pisa
Italy

C. Hulme (Biography
C. Hulme

Dr. Hulme received a doctorate degree (D.Phil) in chemistry from the University of Oxford, England. He currently is a full Professor at the University of Arizona and Director of the Medicinal Chemistry BIO5 Drug Discovery Core. Prior to moving to academia, Dr. Hulme built and managed several high-throughput medicinal chemistry organizations in industry (1994 – 2007, Sanofi, Amgen, Lilly), spanning a multitude of therapeutic areas including neurodegeneration through the targeting of CNS kinases. Dr Hulme has > 175 publications, book chapters, and patents.

)

University of Arizona
Oro Valley, AZ
USA

K. Parang (Biography
K. Parang

Dr. Parang is Associate Dean of Research, Graduate Studies and Global Affairs and a Full Professor of Medicinal Chemistry and Pharmacology at Chapman University School of Pharmacy in Irvine, California. He earned a Pharm.D. degree from Tehran University of Medical Sciences in 1989. He received his Ph.D. in medicinal chemistry from the Faculty of Pharmacy at University of Alberta in 1997, followed by a postdoctoral study in the fields of carbohydrate chemistry and solid-phase organic synthesis in Department of Chemistry. He pursued additional postdoctoral studies at Rockefeller University in New York and Johns Hopkins University in Baltimore in bioorganic chemistry. He is an author of 170 peer-reviewed publications, 8 patents, and more than 140 meeting.

)

Chapman University
CA
USA

S.R. Stauffer (Biography
S.R. Stauffer

Dr. Shaun Stauffer is currently Assistant Professor in the departments of Pharmacology and Chemistry at Vanderbilt University and is associate director of medicinal chemistry within the Vanderbilt Institute for Chemical Biology (VICB) Synthesis Core. Dr. Stauffer received his Ph.D. in 1999 from the University of Illinois developing combinatorial approaches towards selective estrogen receptor modulators in the laboratory of Prof. John Katzenellenbogen. Dr. Stauffer then pursued post-doctoral studies at Yale University as an NIH fellow with Prof. John Hartwig (1999-2001) developing highthroughput screening platforms for reaction discovery and optimization. From 2001-2008 he pursued an industrial career at Merck & Co.

)

Vanderbilt University Medical Center
Nashville, TN
USA












Advertisement

Related Journals




Related eBooks



Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science